Keyphrases
Multiple Sclerosis
100%
Natalizumab
100%
Treatment Response
100%
Vascular Cell Adhesion molecule-1 (VCAM-1)
100%
Whole Blood
100%
MRNA Expression
100%
Expression Response
100%
Serum Concentration
62%
SVCAM-1
50%
Multiple Sclerosis Treatment
50%
Disease Activity
37%
Immune Activation
25%
Interleukin-1β
25%
MRNA Level
25%
Decreased Expression
12%
Immune Parameters
12%
Immune Cells
12%
Blood Samples
12%
Transmigration
12%
Differentially Expressed
12%
Blood-brain Barrier
12%
Immunomodulatory
12%
Activation Status
12%
VLA-4
12%
Immunology and Microbiology
VCAM-1
100%
Multiple Sclerosis
100%
Natalizumab
100%
Blood Level
55%
mRNA Expression Level
22%
Immunocompetent Cell
22%
Immunity
22%
IL1B
22%
Blood Brain Barrier
11%
Neuroscience
VCAM-1
100%
Messenger RNA
100%
Multiple Sclerosis
100%
Natalizumab
100%
IL1B
22%
Blood Brain Barrier
11%